This Arvind Mafatlal operates the largest integrated fluorochemicals complex in India and it also generates a good source of income from sale of Carbon Credits. Its performance for FY11 was subdued but it has begun current fiscal with a big bang. The company posted an unbelievable four-fold jump in net profit at Rs.60.22 crore v/s Rs.15.23 crore on Q1FY11. This is almost close to its entire FY11 net profit of Rs.72 crore. Net sales doubled up to Rs.195 crore. This performance was mainly on the back of robust sales and higher realisations from its refrigerant gas business. Sale of CERs (Certified Emission Reductions or carbon credits) continued in Q1FY12, earning it Rs.64 crore. If one may recollect, the company did not sell any CERs in Q1FY11 no CERs were sold in Q1FY11 due to a suspension of issuance by the UNFCCC. EBIDTA margin stood at a whopping 46% and PAT margin at 31%.
The company recently completed buying back equity shares at a price of Rs.400/share, which is why the equity capital today stands reduced from Rs.10.09 crore to Rs.9.76 crore. It is in the process of restructuring its Organic Chemicals activities including dismantling and redeploying some of the assets of its Dewas unit in other projects currently under implementation at Surat. The Rewas site is now being utilized to set up another state-of-the-art contract manufacturing facility. EPS for Q1FY12 stands at Rs.62, which discounts the current price by around 6 times. For entire FY11, its EPS was at Rs.71. Clearly a fantastic beginning!
Source: Internet (by SP Tulsian)
No comments:
Post a Comment